Rob Wherry

Defense spending is due to increase regardless of which party is in the White House, but the stocks of most contractors already look pricey.

New research lends greater insights into how utilities gain and hold their competitive advantages.

How Morningstar healthcare stock analysts size up the effect of potential legislative proposals.

Valuations look full, as chains such as McDonald's realize turnaround efforts. But good deals are still on the menu.

Emerging from a third-quarter pullback, healthcare companies are preparing for the next phase of the Affordable Care Act.

This TIAA-CREF bond fund puts a new spin on socially responsible investing, and early results show it's working.

Despite low fuel prices pointing toward the contrary, railroads' competitive advantages remain strong against transportation rivals.

With his previous firm Van Kampen now merged away, Alexander Yaggy is racking up strong returns at a new fund.

Comparisons to China are premature, but investors find its long-term growth potential hard to ignore.

David Iben kept a low profile when he left Nuveen Tradewinds, but now the contrarian is back to running a new global all-cap strategy.

Offerings from Oberweis, Rainier, and Seafarer are proving even small funds can be competitive when it comes to picking stocks across the globe.

After several years of mixed returns, investors are rethinking how they get exposure to emerging markets.

Well-regarded manager David Corkins kept a low profile after leaving Janus--until he made a play for like-minded Meridian Funds.

Dale Harvey left the burdens of managing $20 billion for Capital Group to form his own boutique inspired by Thomas Jefferson.

Manager behind the firm's absolute return funds leaves; four comanagers to take over.

Columbia files to launch active ETFs, Eagle secures new team, the SEC backs off money fund reforms, and more.

Oakmark reopens fund, Sentinel managers head to competitor, Lord Abbett makes manager changes and more.

Vanguard Cuts Fees and More.

Wintergreen legal drama ends and more.

Management has announced succession plans.

Plus, Fairholme's Berkowitz will defend stock picks and more ...

Three years into a turnaround, Putnam shows some pluck.

An inside look at how JP Morgan's fund lineup is starting to stand out.